10-Q Filing

XILIO THERAPEUTICS, INC. CIK: 1840233 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001558370-24-008068`
Period End Date	20240331
Filing Date	20240514
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	xlo-20240331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 134 Income Statement 50 Cash Flow Statement 108 Stockholders Equity 26

Balance Sheet 134 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.98M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$93.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$93.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.98M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
License agreement receivable	`ReceivablesNetCurrent`	$30.00M	USD	Point-in-time
License agreement receivable	`ReceivablesNetCurrent`	$30.00M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.42M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.21M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.42M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.21M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$69.19M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$69.19M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$48.13M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$48.13M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.59M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.59M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	34.47M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	34.47M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.61M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.61M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$2.76M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$2.76M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	34.47M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	34.47M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.54M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.61M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.61M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.54M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.00M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.00M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.12M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.12M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$145.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$121.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$121.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$145.00K	USD	Point-in-time
Total assets	`Assets`	$82.61M	USD	Point-in-time
Total assets	`Assets`	$82.61M	USD	Point-in-time
Total assets	`Assets`	$60.93M	USD	Point-in-time
Total assets	`Assets`	$60.93M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.05M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.05M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$746.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$746.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.00M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.00M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.50M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.50M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$21.73M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$21.73M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$1.08M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$1.05M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$1.05M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$1.08M	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$3.31M	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$3.31M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$28.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$28.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$48.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$48.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.96M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.96M	USD	Point-in-time
Deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$17.40M	USD	Point-in-time
Deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$17.40M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$7.86M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$7.86M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$8.14M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$8.14M	USD	Point-in-time
Total liabilities	`Liabilities`	$24.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$56.84M	USD	Point-in-time
Total liabilities	`Liabilities`	$56.84M	USD	Point-in-time
Total liabilities	`Liabilities`	$24.10M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2024 and December 31, 2023; 34,473,486 shares issued and 34,472,646 shares outstanding at March 31, 2024; 27,613,263 shares issued and 27,607,646 shares outstanding at December 31, 2023	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2024 and December 31, 2023; 34,473,486 shares issued and 34,472,646 shares outstanding at March 31, 2024; 27,613,263 shares issued and 27,607,646 shares outstanding at December 31, 2023	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2024 and December 31, 2023; 34,473,486 shares issued and 34,472,646 shares outstanding at March 31, 2024; 27,613,263 shares issued and 27,607,646 shares outstanding at December 31, 2023	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2024 and December 31, 2023; 34,473,486 shares issued and 34,472,646 shares outstanding at March 31, 2024; 27,613,263 shares issued and 27,607,646 shares outstanding at December 31, 2023	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$368.48M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$368.48M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$362.34M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$362.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-325.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-325.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-342.71M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-342.71M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$105.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$36.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$105.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$36.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$84.79M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$25.77M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$25.77M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$84.79M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$82.61M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$60.93M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$82.61M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$60.93M	USD	Point-in-time

Income Statement 50 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$16.13M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$16.13M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$10.40M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$10.40M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.39M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.39M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.14M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.14M	USD	1 Quarter
Restructuring	`RestructuringCharges`	$948.00K	USD	1 Quarter
Restructuring	`RestructuringCharges`	$948.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$17.49M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$17.49M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$23.53M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$23.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-17.49M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-17.49M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$880.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$880.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$284.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$284.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$880.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$880.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$284.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$284.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-17.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-17.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-22.65M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-22.65M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.20M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.20M	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.83	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.83	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.62	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.62	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.83	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.83	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.62	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.62	USD	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.91M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.91M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.43M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.43M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.43M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.91M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.43M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.91M	shares	1 Quarter

Cash Flow Statement 108 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-22.65M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.65M	USD	1 Quarter
Net loss	`ProfitLoss`	$-17.20M	USD	1 Quarter
Net loss	`ProfitLoss`	$-17.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$443.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$443.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$499.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$499.00K	USD	1 Quarter
Non-cash interest (income) expense	`NoncashInterestExpense`	$-1.00K	USD	1 Quarter
Non-cash interest (income) expense	`NoncashInterestExpense`	$-1.00K	USD	1 Quarter
Non-cash interest (income) expense	`NoncashInterestExpense`	$31.00K	USD	1 Quarter
Non-cash interest (income) expense	`NoncashInterestExpense`	$31.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.79M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.79M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.83M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.83M	USD	1 Quarter
License agreement receivable	`IncreaseDecreaseInAccountsReceivable`	$30.00M	USD	1 Quarter
License agreement receivable	`IncreaseDecreaseInAccountsReceivable`	$30.00M	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-406.00K	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-406.00K	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.78M	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.78M	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-108.00K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-108.00K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-127.00K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-127.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-304.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-304.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.36M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.36M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-2.50M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-2.50M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-3.87M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-3.87M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$39.12M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$39.12M	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-244.00K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-244.00K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-213.00K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-213.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.50M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-25.25M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.50M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-25.25M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$170.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$170.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-170.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-170.00K	USD	1 Quarter
Repayments of debt principal	`RepaymentsOfDebt`	$3.33M	USD	1 Quarter
Repayments of debt principal	`RepaymentsOfDebt`	$1.67M	USD	1 Quarter
Repayments of debt principal	`RepaymentsOfDebt`	$1.67M	USD	1 Quarter
Repayments of debt principal	`RepaymentsOfDebt`	$3.33M	USD	1 Quarter
Payments of finance lease	`FinanceLeasePrincipalPayments`	$21.00K	USD	1 Quarter
Payments of finance lease	`FinanceLeasePrincipalPayments`	$21.00K	USD	1 Quarter
Payments of finance lease	`FinanceLeasePrincipalPayments`	$21.00K	USD	1 Quarter
Payments of finance lease	`FinanceLeasePrincipalPayments`	$21.00K	USD	1 Quarter
Proceeds from issuance of common stock under the Gilead stock purchase agreement, net of issuance costs	`ProceedsFromIssuanceOfPrivatePlacement`	$4.31M	USD	1 Quarter
Proceeds from issuance of common stock under the Gilead stock purchase agreement, net of issuance costs	`ProceedsFromIssuanceOfPrivatePlacement`	$4.31M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.69M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.69M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$954.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$954.00K	USD	1 Quarter
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-9.55M	USD	1 Quarter
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-9.55M	USD	1 Quarter
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-27.11M	USD	1 Quarter
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-27.11M	USD	1 Quarter
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.29M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.29M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$94.84M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$94.84M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$94.84M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$94.84M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.29M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.29M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.74M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$62.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$62.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$209.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$209.00K	USD	1 Quarter
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$310.00K	USD	1 Quarter
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$310.00K	USD	1 Quarter
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$21.00K	USD	1 Quarter
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$21.00K	USD	1 Quarter
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$93.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$93.27M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.57M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.57M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$2.76M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$2.76M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.29M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.29M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$94.84M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$94.84M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$25.77M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$25.77M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$84.79M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$84.79M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$36.83M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$36.83M	USD	Point-in-time
Issuance of common stock in connection with the Gilead stock purchase agreement, net of issuance costs (in dollars)	`StockIssuedDuringPeriodValueNewIssues`	$4.31M	USD	1 Quarter
Issuance of common stock in connection with the Gilead stock purchase agreement, net of issuance costs (in dollars)	`StockIssuedDuringPeriodValueNewIssues`	$4.31M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.83M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.83M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.79M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.79M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-17.20M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-17.20M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$36.83M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$25.77M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$25.77M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$84.79M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$84.79M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$36.83M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.